Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 5
2018 6
2019 4
2020 6
2021 14
2022 11
2023 3

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Treatment outcome of atypical EGFR mutations in the German National Network Genomic Medicine Lung Cancer (nNGM).
Janning M, Süptitz J, Albers-Leischner C, Delpy P, Tufman A, Velthaus-Rusik JL, Reck M, Jung A, Kauffmann-Guerrero D, Bonzheim I, Brändlein S, Hummel HD, Wiesweg M, Schildhaus HU, Stratmann JA, Sebastian M, Alt J, Buth J, Esposito I, Berger J, Tögel L, Saalfeld FC, Wermke M, Merkelbach-Bruse S, Hillmer AM, Klauschen F, Bokemeyer C, Buettner R, Wolf J, Loges S; National Network Genomic Medicine Lung Cancer (nNGM). Janning M, et al. Among authors: kauffmann guerrero d. Ann Oncol. 2022 Jun;33(6):602-615. doi: 10.1016/j.annonc.2022.02.225. Epub 2022 Mar 6. Ann Oncol. 2022. PMID: 35263633 Free article.
The impact of TP53 co-mutations and immunologic microenvironment on outcome of lung cancer with EGFR exon 20 insertions.
Christopoulos P, Kluck K, Kirchner M, Lüders H, Roeper J, Falkenstern-Ge RF, Szewczyk M, Sticht F, Saalfeld FC, Wesseler C, Hackanson B, Dintner S, Faehling M, Kuon J, Janning M, Kauffmann-Guerrero D, Kazdal D, Kurz S, Eichhorn F, Bozorgmehr F, Shah R, Tufman A, Wermke M, Loges S, Brueckl WM, Schulz C, Misch D, Frost N, Kollmeier J, Reck M, Griesinger F, Grohé C, Hong JL, Lin HM, Budczies J, Stenzinger A, Thomas M. Christopoulos P, et al. Among authors: kauffmann guerrero d. Eur J Cancer. 2022 Jul;170:106-118. doi: 10.1016/j.ejca.2022.04.020. Epub 2022 May 20. Eur J Cancer. 2022. PMID: 35598358
Black and Blue.
Kauffmann-Guerrero D, Kahnert K, Pratschke S, Angstwurm M, Tufman A, Huber RM. Kauffmann-Guerrero D, et al. Respiration. 2017;94(5):465-466. doi: 10.1159/000479703. Epub 2017 Sep 7. Respiration. 2017. PMID: 28877530 Free article. No abstract available.
Late-onset severe pneumonitis under osimertinib.
Syunyaeva Z, Berghof K, Kauffmann-Guerrero D, Götschke J, Tufman A, Kahnert K. Syunyaeva Z, et al. Among authors: kauffmann guerrero d. AME Case Rep. 2019 Oct 15;3:39. doi: 10.21037/acr.2019.09.01. eCollection 2019. AME Case Rep. 2019. PMID: 31728437 Free PMC article.
SCLC-State of the Art and What Does the Future Have in Store?
Kahnert K, Kauffmann-Guerrero D, Huber RM. Kahnert K, et al. Among authors: kauffmann guerrero d. Clin Lung Cancer. 2016 Sep;17(5):325-333. doi: 10.1016/j.cllc.2016.05.014. Epub 2016 Jun 8. Clin Lung Cancer. 2016. PMID: 27397481 Review.
New developments in locally advanced nonsmall cell lung cancer.
Huber RM, Kauffmann-Guerrero D, Hoffmann H, Flentje M. Huber RM, et al. Among authors: kauffmann guerrero d. Eur Respir Rev. 2021 May 5;30(160):200227. doi: 10.1183/16000617.0227-2020. Print 2021 Jun 30. Eur Respir Rev. 2021. PMID: 33952600 Free PMC article.
46 results